Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia

Purpose The POPPY II cohort is an Australian state-based cohort linking data for a population of individuals prescribed opioid medicines, constructed to allow a robust examination of the long-term patterns and outcomes of prescription opioid use.Participants The cohort includes 3 569 433 adult New S...

Full description

Bibliographic Details
Main Authors: Natasa Gisev, Sallie-Anne Pearson, Timothy Dobbins, David C Currow, Fiona Blyth, Sarah Larney, Adrian Dunlop, Richard P Mattick, Andrew Wilson, Louisa Degenhardt, Thomas Murphy, Luke Buizen
Format: Article
Language:English
Published: BMJ Publishing Group 2023-05-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/5/e068310.full
_version_ 1827213211574730752
author Natasa Gisev
Sallie-Anne Pearson
Timothy Dobbins
David C Currow
Fiona Blyth
Sarah Larney
Adrian Dunlop
Richard P Mattick
Andrew Wilson
Louisa Degenhardt
Thomas Murphy
Luke Buizen
author_facet Natasa Gisev
Sallie-Anne Pearson
Timothy Dobbins
David C Currow
Fiona Blyth
Sarah Larney
Adrian Dunlop
Richard P Mattick
Andrew Wilson
Louisa Degenhardt
Thomas Murphy
Luke Buizen
author_sort Natasa Gisev
collection DOAJ
description Purpose The POPPY II cohort is an Australian state-based cohort linking data for a population of individuals prescribed opioid medicines, constructed to allow a robust examination of the long-term patterns and outcomes of prescription opioid use.Participants The cohort includes 3 569 433 adult New South Wales residents who initiated a subsidised prescription opioid medicine between 2003 and 2018, identified through pharmacy dispensing data (Australian Pharmaceutical Benefits Scheme) and linked to 10 national and state datasets and registries including rich sociodemographic and medical services data.Findings to date Of the 3.57 million individuals included in the cohort, 52.7% were female and 1 in 4 people were aged ≥65 years at the time of cohort entry. Approximately 6% had evidence of cancer in the year prior to cohort entry. In the 3 months prior to cohort entry, 26.9% used a non-opioid analgesic and 20.5% used a psychotropic medicine. Overall, 1 in 5 individuals were initiated on a strong opioid (20.9%). The most commonly initiated opioid was paracetamol/codeine (61.3%), followed by oxycodone (16.3%).Future plans The POPPY II cohort will be updated periodically, both extending the follow-up duration of the existing cohort, and including new individuals initiating opioids. The POPPY II cohort will allow a range of aspects of opioid utilisation to be studied, including long-term trajectories of opioid use, development of a data-informed method to assess time-varying opioid exposure, and a range of outcomes including mortality, transition to opioid dependence, suicide and falls. The duration of the study period will allow examination of population-level impacts of changes to opioid monitoring and access, while the size of the cohort will also allow examination of important subpopulations such as people with cancer, musculoskeletal conditions or opioid use disorder.
first_indexed 2024-03-13T10:41:48Z
format Article
id doaj.art-327b0f8ca20b4806b46526ba53b92155
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2025-03-21T14:11:50Z
publishDate 2023-05-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-327b0f8ca20b4806b46526ba53b921552024-06-24T19:25:10ZengBMJ Publishing GroupBMJ Open2044-60552023-05-0113510.1136/bmjopen-2022-068310Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, AustraliaNatasa Gisev0Sallie-Anne Pearson1Timothy Dobbins2David C Currow3Fiona Blyth4Sarah Larney5Adrian Dunlop6Richard P Mattick7Andrew Wilson8Louisa Degenhardt9Thomas Murphy10Luke Buizen11National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, AustraliaSchool of Population Health, University of New South Wales Medicine & Health, Sydney, New South Wales, AustraliaSchool of Population Health, University of New South Wales - Kensington Campus, Sydney, New South Wales, AustraliaFaculty of Science Medicine and Health, The University of Wollongong, Wollongong, New South Wales, Australia1 Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, AustraliaDepartment of Family Medicine and Emergency Medicine and Centre de Recherche du Centre Hospitalier, de l`Université de Montréal, Montreal, Quebec, CanadaSchool of Medicine and Public Health, The University of Newcastle, Newcastle, New South Wales, AustraliaNational Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, AustraliaMenzies Centre for Health Policy, The University of Sydney, Sydney, New South Wales, Australia6 National Drug and Alcohol Research Centre (NDARC), Faculty of Medicine, University of New South Wales, Sydney, New South Wales, AustraliaNational Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, AustraliaNational Drug and Alcohol Research Centre, UNSW Sydney, Sydney, New South Wales, AustraliaPurpose The POPPY II cohort is an Australian state-based cohort linking data for a population of individuals prescribed opioid medicines, constructed to allow a robust examination of the long-term patterns and outcomes of prescription opioid use.Participants The cohort includes 3 569 433 adult New South Wales residents who initiated a subsidised prescription opioid medicine between 2003 and 2018, identified through pharmacy dispensing data (Australian Pharmaceutical Benefits Scheme) and linked to 10 national and state datasets and registries including rich sociodemographic and medical services data.Findings to date Of the 3.57 million individuals included in the cohort, 52.7% were female and 1 in 4 people were aged ≥65 years at the time of cohort entry. Approximately 6% had evidence of cancer in the year prior to cohort entry. In the 3 months prior to cohort entry, 26.9% used a non-opioid analgesic and 20.5% used a psychotropic medicine. Overall, 1 in 5 individuals were initiated on a strong opioid (20.9%). The most commonly initiated opioid was paracetamol/codeine (61.3%), followed by oxycodone (16.3%).Future plans The POPPY II cohort will be updated periodically, both extending the follow-up duration of the existing cohort, and including new individuals initiating opioids. The POPPY II cohort will allow a range of aspects of opioid utilisation to be studied, including long-term trajectories of opioid use, development of a data-informed method to assess time-varying opioid exposure, and a range of outcomes including mortality, transition to opioid dependence, suicide and falls. The duration of the study period will allow examination of population-level impacts of changes to opioid monitoring and access, while the size of the cohort will also allow examination of important subpopulations such as people with cancer, musculoskeletal conditions or opioid use disorder.https://bmjopen.bmj.com/content/13/5/e068310.full
spellingShingle Natasa Gisev
Sallie-Anne Pearson
Timothy Dobbins
David C Currow
Fiona Blyth
Sarah Larney
Adrian Dunlop
Richard P Mattick
Andrew Wilson
Louisa Degenhardt
Thomas Murphy
Luke Buizen
Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
BMJ Open
title Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
title_full Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
title_fullStr Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
title_full_unstemmed Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
title_short Cohort profile: POPPY II – a population-based cohort examining the patterns and outcomes of prescription opioid use in New South Wales, Australia
title_sort cohort profile poppy ii a population based cohort examining the patterns and outcomes of prescription opioid use in new south wales australia
url https://bmjopen.bmj.com/content/13/5/e068310.full
work_keys_str_mv AT natasagisev cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT sallieannepearson cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT timothydobbins cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT davidccurrow cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT fionablyth cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT sarahlarney cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT adriandunlop cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT richardpmattick cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT andrewwilson cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT louisadegenhardt cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT thomasmurphy cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia
AT lukebuizen cohortprofilepoppyiiapopulationbasedcohortexaminingthepatternsandoutcomesofprescriptionopioiduseinnewsouthwalesaustralia